Abstract:A fundamental challenge in neuroscience is accurately defining brain states and predicting how and where to perturb the brain to force a transition. Here, we investigated resting-state fMRI data of patients suffering from disorders of consciousness (DoC) after coma (minimally conscious and unresponsive wakefulness states) and healthy controls. We applied model-free and model-based approaches to help elucidate the underlying brain mechanisms of patients with DoC. The model-free approach allowed us to characterize brain states in DoC and healthy controls as a probabilistic metastable substate (PMS) space. The PMS of each group was defined by a repertoire of unique patterns (i.e., metastable substates) with different probabilities of occurrence. In the model-based approach, we adjusted the PMS of each DoC group to a causal whole-brain model. This allowed us to explore optimal strategies for promoting transitions by applying off-line in silico probing. Furthermore, this approach enabled us to evaluate the impact of local perturbations in terms of their global effects and sensitivity to stimulation, which is a model-based biomarker providing a deeper understanding of the mechanisms underlying DoC. Our results show that transitions were obtained in a synchronous protocol, in which the somatomotor network, thalamus, precuneus and insula were the most sensitive areas to perturbation. This motivates further work to continue understanding brain function and treatments of disorders of consciousness. We studied disorders of consciousness (DoC) by defining a brain state as a repertoire of metastable substates with different probabilities of occurrence. We created whole-brain computational models of DoC to uncover the causal mechanisms underlying recovery. These models allowed us to simulate transitions by studying the effects of artificial individual local perturbations under different protocol regimes. We demonstrated successful transitions in the synchronization protocol and showed that the most sensitive areas were located in the somatomotor network, thalamus, precuneus and insula. In the long-term, this could bring valuable insights for understanding DoC and open new avenues for future clinical therapies.

Combining brain perturbation and neuroimaging in non-human primates.

Changing Brain Networks Through Non-invasive Neuromodulation

Completing the puzzle: why studies in non-human primates are needed to better understand the effects of non-invasive brain stimulation

Volumetric mesoscopic electrophysiology: a new imaging modality for the non-human primate

In vivo whole brain, cellular and molecular imaging in nonhuman primate models of neuropathology

Imaging-based chemogenetics for dissecting neural circuits in nonhuman primates.

Advances in optogenetic and chemogenetic methods to study brain circuits in non-human primates

Combining magnetic resonance imaging with readout and/or perturbation of neural activity in animal models: Advantages and pitfalls

A Precise and Minimally Invasive Approach to Optogenetics in the Awake Primate

Targeted Patching and Dendritic Ca2+ Imaging in Nonhuman Primate Brain in Vivo.

Cerebro-cerebellar interactions in nonhuman primates examined by optogenetic functional magnetic resonance imaging

What can neuroimaging of neuromodulation reveal about the basis of circuit therapies for psychiatry?

Opportunities and limitations of genetically modified nonhuman primate models for neuroscience research

Non-human Primate Models for Brain Disorders – Towards Genetic Manipulations Via Innovative Technology

Optogenetics Through Windows on the Brain in the Nonhuman Primate.

Opportunities and challenges in modeling human brain disorders in transgenic primates

Advanced Circuit and Cellular Imaging Methods in Nonhuman Primates

The NonHuman Primate Neuroimaging & Neuroanatomy Project

Brains, genes, and primates

Re-awakening the brain: Forcing transitions in disorders of consciousness by external in silico perturbation

Pharmacological MRI combined with electrophysiology in non-human primates: Effects of Lidocaine on primary visual cortex